On the public citation graph
The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder
0 signed · 49 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamanetworkopen.2019.0338openalex-snapshot
Association of Criminal Statutes for Opioid Use Disorder With Prevalence and Treatment Among Pregnant Women With Commercial Insurance in the United States
inferredcites →https://doi.org/10.1007/s10862-012-9323-4openalex-snapshot
Self-Stigma in Substance Abuse: Development of a New Measure
inferredcites →https://doi.org/10.1007/s11414-018-9629-4openalex-snapshot
Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment
inferredcites →https://doi.org/10.1007/s11606-020-06255-6openalex-snapshot
Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care
inferredcites →https://doi.org/10.1007/s11606-020-06257-4openalex-snapshot
Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review
inferredcites →https://doi.org/10.1007/s11904-018-0402-3openalex-snapshot
Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment
inferredcites →https://doi.org/10.1016/c2018-0-04198-5openalex-snapshot
The Opioid Epidemic and Infectious Diseases
inferredcites →https://doi.org/10.1016/j.drugalcdep.2015.02.030openalex-snapshot
Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study
inferredcites →https://doi.org/10.1016/j.drugalcdep.2018.12.030openalex-snapshot
Co-occurring substance use and mental disorders among adults with opioid use disorder
inferredcites →https://doi.org/10.1016/j.drugalcdep.2019.107654openalex-snapshot
State criminal justice policy context and opioid agonist treatment delivery among opioid treatment admissions, 2015
inferredcites →https://doi.org/10.1016/j.drugalcdep.2021.108710openalex-snapshot
Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017
inferredcites →https://doi.org/10.1016/j.jsat.2019.07.005openalex-snapshot
Buprenorphine in the United States: Motives for abuse, misuse, and diversion
inferredcites →https://doi.org/10.1016/j.jsat.2020.108008openalex-snapshot
Characterizing variability in state-level regulations governing opioid treatment programs
inferredcites →https://doi.org/10.1016/j.jsat.2021.108329openalex-snapshot
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings
inferredcites →https://doi.org/10.1016/s0140-6736(17)32812-xopenalex-snapshot
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
inferredcites →https://doi.org/10.1016/s0740-5472(02)00241-6openalex-snapshot
Adoption and implementation of new technologies in substance abuse treatment
inferredcites →https://doi.org/10.1056/nejmra1604339openalex-snapshot
Treatment of Opioid-Use Disorders
inferredcites →https://doi.org/10.1080/00223891.1990.9674095openalex-snapshot
Psychometric Characteristics of the Multidimensional Scale of Perceived Social Support
inferredcites →https://doi.org/10.1080/08897077.2015.1080208openalex-snapshot
Policies Related to Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013
inferredcites →https://doi.org/10.1080/08897077.2021.1891492openalex-snapshot
The Who, the What, and the How: A Description of Strategies and Lessons Learned to Expand Access to Medications for Opioid Use Disorder in Rural America
inferredcites →https://doi.org/10.1093/jssam/smx019openalex-snapshot
Trends in U.S. Face-To-Face Household Survey Nonresponse and Level of Effort
inferredcites →https://doi.org/10.1097/mlr.0000000000001394openalex-snapshot
Relative Cost Differences of Initial Treatment Strategies for Newly Diagnosed Opioid Use Disorder
inferredcites →https://doi.org/10.1111/1475-6773.13113openalex-snapshot
County‐level access to opioid use disorder medications in medicare Part D (2010‐2015)
inferredcites →https://doi.org/10.1111/add.13238openalex-snapshot
Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial
inferredcites →https://doi.org/10.1177/2150132720931720openalex-snapshot
Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice
inferredcites →https://doi.org/10.1207/s15327752jpa5201_2openalex-snapshot
The Multidimensional Scale of Perceived Social Support
inferredcites →https://doi.org/10.1595/003214075x1912929openalex-snapshot
An Age-hardenable Palladium Based Spring Alloy
inferredcites →https://doi.org/10.17226/25310openalex-snapshot
Medications for Opioid Use Disorder Save Lives
inferredcites →https://doi.org/10.31478/202004bopenalex-snapshot
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers Within the Treatment System
inferredcites →https://doi.org/10.7326/m18-0227openalex-snapshot
Cost-Effectiveness of Buprenorphine–Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4774188openalex-extracted
Closing the Opioid Use Disorder Treatment Gap: Expanding Nurse Practitioners' Prescriptive Authority
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.4617openalex-snapshot
Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder
inferred← citeshttps://doi.org/10.1016/j.acepjo.2025.100192openalex-snapshot
Emergency Department-Based Medication for Opioid Use Disorder: A 5-Year Experience
inferred← citeshttps://doi.org/10.1016/j.addicn.2026.100256openalex-snapshot
Effects of prenatal methadone and buprenorphine exposure on motivated responding for sucrose and gene expression in adult male and female rats
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209310openalex-snapshot
Barriers to retention in medications for opioid use disorder treatment in real-world practice
inferred← citeshttps://doi.org/10.1016/j.josat.2026.210076openalex-snapshot
Mindfulness-based interventions for opioid misuse: A systematic review of randomized controlled trials
inferred← citeshttps://doi.org/10.1080/10550887.2026.2642730openalex-snapshot
Quality of life in people who inject drugs correlate with discharge outcomes and medication therapy initiation
inferred← citeshttps://doi.org/10.1080/15504263.2026.2729324openalex-snapshot
Specific Mental Disorder Comorbidities and MOUD Receipt for Opioid Misuse: Lower Receipt for Persons with Psychotic Disorders
inferred← citeshttps://doi.org/10.1111/ajad.70035openalex-snapshot
Pain intensity in patients using extended‐release naltrexone or opioid agonists and its effect on extended‐release naltrexone treatment outcomes
inferred← citeshttps://doi.org/10.1177/00220426251394665openalex-snapshot
Barriers to Substance Use Treatment Among Criminal Legal System-Involved Women With Opioid Use Disorder
inferred← citeshttps://doi.org/10.1177/02698811261478613openalex-snapshot
Differential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice
inferred← citeshttps://doi.org/10.1177/29767342241266038openalex-snapshot
Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals with Opioid Use Disorder: A Cohort Study
inferred← citeshttps://doi.org/10.1177/29767342261426117openalex-snapshot
Influence of Attitudes on Recovery Residence Acceptance and Use of Medication for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1186/s13722-025-00576-9openalex-snapshot
High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study
inferred← citeshttps://doi.org/10.21203/rs.3.rs-10317126/v1openalex-snapshot
Medicaid Expansion and Implementation of Medication for Opioid Use Disorder Treatment Planning in U.S. Publicly Funded Specialty Treatment Systems
inferred← citeshttps://doi.org/10.2139/ssrn.5458595openalex-snapshot
The Last Mile to First Treatment: Search for Opioid Use Disorder Medication
inferred← citeshttps://doi.org/10.3390/bs16010122openalex-snapshot
Retention on Buprenorphine for Opioid Use Disorder in Justice-Involved Individuals: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.51922/2074-5044.2026.3.82openalex-snapshot
Treating opioid addiction with opioids: groundbreaking science or absolute chaos?
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.